Mersana Therapeutics logo

Mersana Therapeutics Share Price Today

(NASDAQ: MRSN)

Mersana Therapeutics share price is $0.36 & ₹30.76 as on 26 Apr 2025, 2.30 'hrs' IST

$0.36

Live

View live Mersana Therapeutics share price in Dollar and Rupees. Guide to invest in Mersana Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mersana Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Mersana Therapeutics share price movements

  • Today's Low: $0.35
    Today's High: $0.37

    Day's Volatility :5.79%

  • 52 Weeks Low: $0.26
    52 Weeks High: $3.63

    52 Weeks Volatility :92.87%

Mersana Therapeutics (MRSN) Returns

PeriodMersana Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-43.68%
-4.8%
0.0%
6 Months
-80.93%
-7.5%
0.0%
1 Year
-87.29%
-1.8%
0.0%
3 Years
-90.23%
2.1%
-9.5%

Mersana Therapeutics (MRSN) Key Statistics

in dollars & INR

Previous Close
$0.3623
Open
$0.37
Today's High
$0.3715
Today's Low
$0.35
Market Capitalization
$48.6M
Today's Volume
$1.9M
52 Week High
$3.63
52 Week Low
$0.2589
Revenue TTM
$40.5M
EBITDA
$-71.7M
Earnings Per Share (EPS)
$-0.57
Profit Margin
-170.86%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-505.14%

How to invest in Mersana Therapeutics Stock (MRSN) from India?

It is very easy for Indian residents to invest directly in Mersana Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mersana Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mersana Therapeutics or MRSN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mersana Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mersana Therapeutics shares which would translate to 2.374 fractional shares of Mersana Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mersana Therapeutics, in just a few clicks!

Returns in Mersana Therapeutics (MRSN) for Indian investors in Rupees

The Mersana Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mersana Therapeutics investment value today

Current value as on today

₹15,207

Returns

₹84,793

(-84.79%)

Returns from Mersana Therapeutics Stock

₹87,368 (-87.37%)

Dollar Returns

₹2,575 (+2.58%)

Indian investors sentiment towards Mersana Therapeutics (MRSN)

-27%

Period: Mar 25, 2025 to Apr 24, 2025. Change in 30 Days versus previous period

Search interest for Mersana Therapeutics Stock from India on INDmoney has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Mersana Therapeutics

  • Nextech Invest AG

    9.68%

  • EcoR1 Capital, LLC

    9.09%

  • VR Adviser, LLC

    8.23%

  • BlackRock Inc

    7.39%

  • Bain Capital Life Sciences Investors, LLC

    6.95%

  • Vanguard Group Inc

    5.66%

Analyst Recommendation on Mersana Therapeutics

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Mersana Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Mersana Therapeutics Stock (MRSN)

What analysts predicted

Upside of 1209.53%

Target:

$4.71

Current:

$0.36

Insights on Mersana Therapeutics Stock (Ticker Symbol: MRSN)

  • Price Movement

    In the last 6 months, MRSN stock has moved down by -80.9%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 2.29M → 16.36M (in $), with an average increase of 52.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -11.50M → -14.11M (in $), with an average decrease of 22.8% per quarter
  • MRSN vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 72.4% return, outperforming this stock by 159.7%
  • MRSN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 57.3% return, outperforming this stock by 148.3%
  • Price to Sales

    ForMRSN every $1 of sales, investors are willing to pay $1.1, whereas for Beone Medicines Ltd, the investors are paying $7.1 for every $1 of sales.

Mersana Therapeutics Technicals Summary

Sell

Neutral

Buy

Mersana Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Mersana Therapeutics (MRSN) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Mersana Therapeutics Inc logo
-11.66%
-80.93%
-87.29%
-90.23%
-95.81%
Regeneron Pharmaceuticals, Inc. logo
-6.31%
-35.72%
-32.66%
-11.12%
9.54%
Beone Medicines Ltd logo
2.09%
20.37%
72.43%
67.9%
55.25%
Vertex Pharmaceuticals Incorporated logo
-1.56%
3.09%
23.83%
83.97%
83.41%
Alnylam Pharmaceuticals, Inc. logo
-9.88%
-14.83%
68.82%
56.52%
70.01%

About Mersana Therapeutics

Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs. The company develops Emi-Le (XMT-1660), a B7-H4-targeting Dolasynthen ADC candidate, which is in Phase 1 clinical trial; and XMT-2056, an Immunosynthen ADC targeting a novel human epidermal growth factor receptor 2 that is in Phase 1 clinical trial. Its preclinical products portfolio includes XMT-2068 and XMT-2175. It has strategic research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana Biosciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.
Organization
Mersana Therapeutics
Employees
102
CEO
Dr. Martin H. Huber M.D.
Industry
Health Technology

Management People of Mersana Therapeutics

NameTitle
Dr. Martin H. Huber M.D.
President, CEO & Director
Mr. Brian C. DeSchuytner
Senior VP, CFO & COO
Dr. Timothy B. Lowinger Ph.D.
Senior VP and Chief Science & Technology Officer
Ms. Alejandra Veronica Carvajal J.D.
Senior VP, Secretary & Chief Legal Officer
Mr. Mohan Bala Ph.D.
Senior VP & Chief Development Officer
Mr. Mikhail Papisov Ph.D.
Co-Founder
Mr. Ashish Mandelia
VP & Chief Accounting Officer
Mr. Jason Fredette
Senior Vice President of Investor Relations & Corporate Communications
Mr. Chuck Miller
Senior Vice President of Regulatory Affairs
Dr. Marc Damelin Ph.D.
Exe. Director and Head of Biology, Oncology, Antibody-Drug Conjugate ADC Discovery & Develop.

Important FAQs about investing in MRSN Stock from India :

What is Mersana Therapeutics share price today?

Mersana Therapeutics share price today stands at $0.36, Open: $0.39 ; Previous Close: $0.36 ; High: $0.37 ; Low: $0.35 ; 52 Week High: $3.63 ; 52 Week Low: $0.26.

The stock opens at $0.39, after a previous close of $0.36. The stock reached a daily high of $0.37 and a low of $0.35, with a 52-week high of $3.63 and a 52-week low of $0.26.

Can Indians buy Mersana Therapeutics shares?

Yes, Indians can invest in the Mersana Therapeutics (MRSN) from India.

With INDmoney, you can buy Mersana Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Mersana Therapeutics at zero transaction cost.

How can I buy Mersana Therapeutics shares from India?

It is very easy to buy Mersana Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mersana Therapeutics (MRSN) be purchased?

Yes, you can buy fractional shares of Mersana Therapeutics with INDmoney app.

What are the documents required to start investing in Mersana Therapeutics stocks?

To start investing in Mersana Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Mersana Therapeutics Stock (MRSN)?

Today’s highest price of Mersana Therapeutics (MRSN) is $0.37.

Today’s lowest price of Mersana Therapeutics (MRSN) is $0.35.

What is today's market capitalisation of Mersana Therapeutics?

Today's market capitalisation of Mersana Therapeutics MRSN is 48.6M

What is the 52 Week High and Low Range of Mersana Therapeutics Stock (MRSN)?

  • 52 Week High

    $3.63

  • 52 Week Low

    $0.26

What are the historical returns of Mersana Therapeutics (MRSN)?

  • 1 Month Returns

    -11.66%

  • 3 Months Returns

    -80.93%

  • 1 Year Returns

    -87.29%

  • 5 Years Returns

    -95.81%

Who is the Chief Executive Officer (CEO) of Mersana Therapeutics ?

Dr. Martin H. Huber M.D. is the current Chief Executive Officer (CEO) of Mersana Therapeutics.